NCT05672407

The Role of Local Tranexamic Acid on Periorbital Oculoplastic Surgery

• Status: Withdrawn
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: University of Miami · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study investigates the effect of tranexamic acid, a medication that helps reduce bleeding, in patients undergoing surgeries around their eyes.

Conditions

• Eyelid Diseases
• Periorbital Disorder
• Hemorrhage
• Surgical Blood Loss

Interventions

Type	Name	Description
DRUG	Tranexamic acid	100 mg/mL Tranexamic acid with lidocaine with 1:100,000 epinephrine in 1:1 manner administered subcutaneously
DRUG	Placebo	Lidocaine with 1:100,000 epinephrine mixed with 1:1 Basal Saline Solution (BSS) administered subcutaneously

Timeline

• Start date: 2023-09-01
• Primary completion: 2026-06-01
• Completion: 2026-06-01
• First posted: 2023-01-05
• Last updated: 2023-09-21

Regulatory

• FDA-regulated drug study